JAMES LAMON: Open Payments
NPI 1013019033 · MOULTRIE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$892 in 33 payments from 14 companies in 2025. Trend: 2023 $1,556 · 2024 $999 · 2025 $892
Food & beverage: $617Gift: $275
| Company | Payments | Amount |
|---|---|---|
| Sekisui Diagnostics LLC | 1 | $275 |
| Amgen Inc. | 10 | $160 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $85 |
| Boston Scientific Corporation | 2 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| Aimmune Therapeutics, Inc. | 2 | $48 |
| Exact Sciences Corporation | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $37 |
| ABBVIE INC. | 2 | $34 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: EVENITY, Kerendia, OTEZLA, WATCHMAN Access System, ZENPEP, AIRSUPRA, TRELEGY ELLIPTA, GVOKE HYPOPEN.
Industry payments across GA — which companies pay providers there.
